However, the immunity-related functions of p53 are partially associated with its anti-oncogenic functions; e.g., hypothetically, p53 may make incipient cancer cells better targets for cytotoxic lymphocytes or natural killer (NK) cells. The gene discussed is TP53; the disease is cancer.